Arbutus Biopharma Corp (ABUS) stock is higher by 37.54% over the past week and gets a Bullish rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With ABUS Stock Today?
Arbutus Biopharma Corp (ABUS) stock is lower by -5.63% while the S&P 500 has risen 0.13% as of 11:16 AM on Wednesday, Dec 16. ABUS is lower by -$0.28 from the previous closing price of $4.97 on volume of 2,741,800 shares. Over the past year the S&P 500 is higher by 15.92% while ABUS has risen 110.31%. ABUS lost -$1.24 per share in the over the last 12 months.
To see InvestorsObserver's Sentiment Score for Arbutus Biopharma Corp click here.
More About Arbutus Biopharma Corp
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops and commercializes cure for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and also involved in licensing of Lipid nanoparticle technology.
Click Here to get the full Stock Score Report on Arbutus Biopharma Corp (ABUS) Stock.
